AGP Executive Report
Last update: 10 hours agoRescheduling shockwaves: The DOJ’s move to reclassify certain medical cannabis products to Schedule III is now raising two big industry questions at once—cheaper access and whether medical users could legally buy firearms via federal dealer forms. Science & standards: A new study warns that common nitrile lab gloves may contaminate microplastics readings, potentially inflating results and forcing labs to re-check methods. Policy & enforcement: In Ireland, a “vulnerable” couple jailed for drug supply at home underscores how courts treat cannabis-linked trafficking as a serious public-safety role. Market & tech: Algorae says it finished its AI prediction phase for expanded drug combinations beyond cannabidiol, while Safe Harbor Financial reports Q1 gains tied to its regulated cannabis/hemp lending platform. Public health watch: Illinois students hospitalized after pot gummy ingestion keeps the spotlight on child-proofing and school safety.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
